Latest Articles
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment - The American Journal of Managed Care® (AJMC®)
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment The American Journal of Managed Care® (AJMC®)
Published: May 8, 2026, 4:51 p.m.
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment - AJMC
Endometriosis Has a Metabolism Problem, and Targeting It Could Transform Treatment AJMC
Published: May 8, 2026, 4:51 p.m.
Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView
Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView
Published: May 7, 2026, 12:05 p.m.
FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan
FDA clears new dual-target cancer drug for ovarian, endometrial trial Stock Titan
Published: May 7, 2026, 12:02 p.m.
New Endometrial Targets Beyond HER2 - OncLive
New Endometrial Targets Beyond HER2 OncLive
Published: May 5, 2026, 12:06 p.m.
New Theranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer [IMAGE] - EurekAlert!
New Theranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer [IMAGE] EurekAlert!
Published: April 30, 2026, 9:35 p.m.
Back-to-school shopping? Teachers and students can get 20% off with Target Circle - Mashable
Back-to-school shopping? Teachers and students can get 20% off with Target Circle Mashable
Published: April 25, 2026, 9 a.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 riauone.com
Published: April 24, 2026, 4:01 a.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 - The Manila Times
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 The Manila Times
Published: April 21, 2026, 9:40 p.m.
SGO 2026: Ovarian OS Gains and New Endometrial Targets - Medscape
SGO 2026: Ovarian OS Gains and New Endometrial Targets Medscape
Published: April 17, 2026, 6:56 p.m.
Link copied to clipboard!